Living near green spaces linked to stronger bones in young children

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

Lyell Im­munophar­ma is lay­ing off 25% of its work­force, and its chief med­ical of­fi­cer is leav­ing, ac­cord­ing to the Bay Area biotech com­pa­ny’s third-quar­ter re­port.